Interestingly, RBM10 still reduced c-Myc protein levels (SI Appendix, Fig. S5C) even when lung cancer cells were treated with Isoginkgetin, a small molecule inhibitor of pre-mRNA splicing (36). This evidence concerns the gene MYC and lung carcinoma.